CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULOPATHY

Clinical trials for CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULOPATHY explained in plain language.

Never miss a new study

Get alerted when new CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULOPATHY trials appear

Sign up with your email to follow new studies for CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Experimental cell therapy targets Hard-to-Treat nerve diseases

Disease control Recruiting now

This early-stage study tests a new cell therapy called CNCT19 in 18 adults with relapsed or treatment-resistant autoimmune neurological diseases like neuromyelitis optica. The goal is to see if it is safe and can help control the disease by targeting certain immune cells. Partici…

Matched conditions: CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULOPATHY

Phase: EARLY_PHASE1 • Sponsor: Juventas Cell Therapy Ltd. • Aim: Disease control

Last updated Jun 27, 2026 09:10 UTC

CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULOPATHY

Get alerted when new CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULOPATHY trials appear

Experimental cell therapy targets Hard-to-Treat nerve diseases